Holdings
Deep Track Capital, LP
As of Jun 30, 2026, Deep Track Capital, LP reported 60 positions worth US$5.92B. Largest: Guardant Health, Inc., Immunovant, Inc. and Vaxcyte, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Guardant Health, Inc. | 3.39M | US$509M | +55,071 | Jun 30, 2026 |
| Immunovant, Inc. | 9.34M | US$360M | −2.19M | Jun 30, 2026 |
| Vaxcyte, Inc. | 4.3M | US$250M | no change | Jun 30, 2026 |
| Alnylam Pharmaceuticals, Inc. | 825K | US$248M | new | Jun 30, 2026 |
| Veradermics, Incorporated | 2M | US$246M | +1.5M | Jun 30, 2026 |
| Tarsus Pharmaceuticals, Inc. | 3.67M | US$231M | +66,768 | Jun 30, 2026 |
| Nuvalent, Inc. | 1.78M | US$220M | +407K | Jun 30, 2026 |
| Ocular Therapeutix, Inc. | 19.7M | US$193M | no change | Jun 30, 2026 |
| Biomarin Pharmaceutical Inc. | 3.31M | US$189M | +2.16M | Jun 30, 2026 |
| Nurix Therapeutics, Inc. | 7.74M | US$188M | +1.39M | Jun 30, 2026 |